The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients. (SeCOVID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04869579
Recruitment Status : Unknown
Verified July 2021 by Mohamed Ghoweba, MD, CHRISTUS Health.
Recruitment status was:  Not yet recruiting
First Posted : May 3, 2021
Last Update Posted : August 3, 2021
Pharco Pharmaceuticals
Information provided by (Responsible Party):
Mohamed Ghoweba, MD, CHRISTUS Health

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : November 15, 2021
Estimated Study Completion Date : December 15, 2021